Screening of individuals who have a high risk of pancreatic ductal adenocarcinoma (PDAC), due to genetic factors, frequently leads to identification of pancreatic lesions.
We investigated the incidence of PDAC and risk factors for neoplastic progression in individuals at high risk for PDAC enrolled in a long-term screening study. Read more . . .